Understanding the immune response to COVID-19

Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2

NIH-funded research Cedars-Sinai Medical Center · NIH-11171035

This study is looking at how different people's bodies react to the COVID-19 virus, especially how their immune systems respond, and it's for anyone with COVID-19 or healthcare workers, as it aims to learn more about how the illness progresses and what helps people recover.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center NIH-funded
Lab location1 site (Los Angeles, United States)
Project IDNIH-11171035 on NIH RePORTER

What this research studies

This research investigates how different individuals respond to the SARS-CoV-2 virus, focusing on the immune and inflammatory responses that can affect the severity of COVID-19. By studying patients with confirmed or suspected COVID-19 and healthcare workers, the research aims to gather extensive data on illness progression, recovery, and potential immunity. The approach includes longitudinal data collection and analysis to identify risk factors and outcomes associated with COVID-19. Patients will be monitored over time to better understand their immune responses and the factors that influence their health.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals who have been diagnosed with COVID-19 or healthcare workers involved in treating COVID-19 patients.

Not a fit: Patients who have not been exposed to SARS-CoV-2 or those without any symptoms related to COVID-19 may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding of COVID-19, helping to identify at-risk populations and inform better treatment strategies.

How similar studies have performed: Other research has shown success in understanding immune responses to viral infections, making this approach promising but still requiring further exploration specific to COVID-19.

Where this research is happening

Los Angeles, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autoimmune Diseases
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.